Expression of accessory molecules on antigen presenting cells in patients with drug eruption, toxicoderma and inflammatory skin disease

Expression of accessory molecules on antigen presenting cells in patients with drug eruption, toxicoderma and inflammatory skin disease - Expression of accessory molecules on antigen presenting cells in skin disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008717

Enrollment

100

Registered

2012-08-17

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug eruption, toxicoderma and inflammatory skin disease

Interventions

Blood examination Skin biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with drug eruption, toxicoderma and inflammatory skin disease

Exclusion criteria

Exclusion criteria: Patients disqualified by the doctor

Design outcomes

Primary

Measure	Time frame
Comparison of expression profiles of accessory molecules on antigen presenting cells associated with clinical course.	—

Countries

Japan

Contacts

Public ContactTomoya Watanabe

Yokohama City University Graduate School of Medicine Department of Environmental Immuno-Dermatology

nabetomo0968@yahoo.co.jp045-787-2675

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026